SARS-CoV-IN-3

• CAT Number: I016218
• CAS Number: 888958-27-8
• Molecular Formula: C₂₅H₂₀ClFeN₃O
• Molecular Weight: 469.74
• Purity: ≥95%
• Target: SARS-CoV

SARS-CoV-IN-3（Cat No.:I016218）is a potent inhibitor of SARS-CoV-2, the virus responsible for COVID-19. It specifically targets the viral 3C-like protease (3CLpro), an essential enzyme for viral replication, preventing the cleavage of viral polyproteins and disrupting the virus’s life cycle. This compound shows high selectivity and efficacy in inhibiting SARS-CoV-2 replication in vitro. SARS-CoV-IN-3 is an important candidate in the ongoing search for antiviral therapies and is considered a promising tool in the development of treatments against SARS-CoV-2 and related coronaviruses.

Reference

[1]. Biot C, et al. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006 May 4;49(9):2845-9.